Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Pandemic influenza surveillance in the valencian community and seasonal influenza vaccines].

Identifieur interne : 000424 ( Main/Exploration ); précédent : 000423; suivant : 000425

[Pandemic influenza surveillance in the valencian community and seasonal influenza vaccines].

Auteurs : Rosa María Carb Malonda [Espagne] ; Francisco González Morán ; Hermelinda Vanaclocha Luna ; Miguel Martín-Sierra Balibrea ; Silvia Guiral Rodrigo ; Elvira Pérez Pérez ; Teresa Castellanos Martínez

Source :

RBID : pubmed:21203724

Descripteurs français

English descriptors

Abstract

BACKGROUND

Surveillance of Pandemic influenza was carried out in the Valencian Community. Some effectiveness studies of the seasonal vaccine for AnH1N1 virus have presented no consistent results. The objective of the work consists on describing the results of the epidemic surveillance and effectiveness of the seasonal vaccine for pandemic influenza in the weeks 28 to 51, 2009.

METHODS

We studied the cases in primary care, hospitalized confirmed, Polimerase Chain Reaction (PCR) and viral isolates and vaccine coverage. Vaccine effectiveness was calculated by the Farrington method of screening method, in three age groups, and two periods: vaccinated 2008-9 and 2009-10 seasons.

RESULTS

In the first period (weeks 28-40) the incidence rates were highest in the group of 15-64 years (7207 cases), followed by those under 15 years (1596 cases). In the second period (weeks 45-47) children under 15 years (28218 cases) were the most affected. In both periods incidence in patients older than 65 years was low (rates of 56,3 and 125,1 respectively). In the studied period (weeks 28 at 51) 5481 cases were confirmed, of those that 1746 (31,8%) were hospitalized. The curve of hospitalization rate showed a profile similar to those in primary care and also in microbiological surveillance of the virus. The vaccine effectiveness in the second period was 25% in adults between 15 and 64 years and 51% in those older than 64 years.

CONCLUSIONS

There is an age-dependent protection with positive vaccine efficacy in the elderly, although it may be confounded by natural exposure to the virus, previous immunizations or immune response.


DOI: 10.1590/s1135-57272010000500013
PubMed: 21203724


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Pandemic influenza surveillance in the valencian community and seasonal influenza vaccines].</title>
<author>
<name sortKey="Carb Malonda, Rosa Maria" sort="Carb Malonda, Rosa Maria" uniqKey="Carb Malonda R" first="Rosa María" last="Carb Malonda">Rosa María Carb Malonda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Área de Epidemiología, Dirección General de Salud Pública, Consellería de Sanitat de la Comunitat Valenciana, Valencia, Spain. silvia.fermamdez@salud.madrid.org</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Área de Epidemiología, Dirección General de Salud Pública, Consellería de Sanitat de la Comunitat Valenciana, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gonzalez Moran, Francisco" sort="Gonzalez Moran, Francisco" uniqKey="Gonzalez Moran F" first="Francisco" last="González Morán">Francisco González Morán</name>
</author>
<author>
<name sortKey="Vanaclocha Luna, Hermelinda" sort="Vanaclocha Luna, Hermelinda" uniqKey="Vanaclocha Luna H" first="Hermelinda" last="Vanaclocha Luna">Hermelinda Vanaclocha Luna</name>
</author>
<author>
<name sortKey="Martin Sierra Balibrea, Miguel" sort="Martin Sierra Balibrea, Miguel" uniqKey="Martin Sierra Balibrea M" first="Miguel" last="Martín-Sierra Balibrea">Miguel Martín-Sierra Balibrea</name>
</author>
<author>
<name sortKey="Guiral Rodrigo, Silvia" sort="Guiral Rodrigo, Silvia" uniqKey="Guiral Rodrigo S" first="Silvia" last="Guiral Rodrigo">Silvia Guiral Rodrigo</name>
</author>
<author>
<name sortKey="Perez Perez, Elvira" sort="Perez Perez, Elvira" uniqKey="Perez Perez E" first="Elvira" last="Pérez Pérez">Elvira Pérez Pérez</name>
</author>
<author>
<name sortKey="Castellanos Martinez, Teresa" sort="Castellanos Martinez, Teresa" uniqKey="Castellanos Martinez T" first="Teresa" last="Castellanos Martínez">Teresa Castellanos Martínez</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010 Sep-Oct</date>
<idno type="RBID">pubmed:21203724</idno>
<idno type="pmid">21203724</idno>
<idno type="doi">10.1590/s1135-57272010000500013</idno>
<idno type="wicri:Area/Main/Corpus">00414</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00414</idno>
<idno type="wicri:Area/Main/Curation">000414</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000414</idno>
<idno type="wicri:Area/Main/Exploration">000414</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Pandemic influenza surveillance in the valencian community and seasonal influenza vaccines].</title>
<author>
<name sortKey="Carb Malonda, Rosa Maria" sort="Carb Malonda, Rosa Maria" uniqKey="Carb Malonda R" first="Rosa María" last="Carb Malonda">Rosa María Carb Malonda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Área de Epidemiología, Dirección General de Salud Pública, Consellería de Sanitat de la Comunitat Valenciana, Valencia, Spain. silvia.fermamdez@salud.madrid.org</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Área de Epidemiología, Dirección General de Salud Pública, Consellería de Sanitat de la Comunitat Valenciana, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gonzalez Moran, Francisco" sort="Gonzalez Moran, Francisco" uniqKey="Gonzalez Moran F" first="Francisco" last="González Morán">Francisco González Morán</name>
</author>
<author>
<name sortKey="Vanaclocha Luna, Hermelinda" sort="Vanaclocha Luna, Hermelinda" uniqKey="Vanaclocha Luna H" first="Hermelinda" last="Vanaclocha Luna">Hermelinda Vanaclocha Luna</name>
</author>
<author>
<name sortKey="Martin Sierra Balibrea, Miguel" sort="Martin Sierra Balibrea, Miguel" uniqKey="Martin Sierra Balibrea M" first="Miguel" last="Martín-Sierra Balibrea">Miguel Martín-Sierra Balibrea</name>
</author>
<author>
<name sortKey="Guiral Rodrigo, Silvia" sort="Guiral Rodrigo, Silvia" uniqKey="Guiral Rodrigo S" first="Silvia" last="Guiral Rodrigo">Silvia Guiral Rodrigo</name>
</author>
<author>
<name sortKey="Perez Perez, Elvira" sort="Perez Perez, Elvira" uniqKey="Perez Perez E" first="Elvira" last="Pérez Pérez">Elvira Pérez Pérez</name>
</author>
<author>
<name sortKey="Castellanos Martinez, Teresa" sort="Castellanos Martinez, Teresa" uniqKey="Castellanos Martinez T" first="Teresa" last="Castellanos Martínez">Teresa Castellanos Martínez</name>
</author>
</analytic>
<series>
<title level="j">Revista espanola de salud publica</title>
<idno type="ISSN">1135-5727</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza Vaccines (MeSH)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Population Surveillance (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Time Factors (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Facteurs temps (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Vaccins antigrippaux (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Humans</term>
<term>Infant</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Population Surveillance</term>
<term>Seasons</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Nourrisson</term>
<term>Pandémies</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Surveillance de la population</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Surveillance of Pandemic influenza was carried out in the Valencian Community. Some effectiveness studies of the seasonal vaccine for AnH1N1 virus have presented no consistent results. The objective of the work consists on describing the results of the epidemic surveillance and effectiveness of the seasonal vaccine for pandemic influenza in the weeks 28 to 51, 2009.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>We studied the cases in primary care, hospitalized confirmed, Polimerase Chain Reaction (PCR) and viral isolates and vaccine coverage. Vaccine effectiveness was calculated by the Farrington method of screening method, in three age groups, and two periods: vaccinated 2008-9 and 2009-10 seasons.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>In the first period (weeks 28-40) the incidence rates were highest in the group of 15-64 years (7207 cases), followed by those under 15 years (1596 cases). In the second period (weeks 45-47) children under 15 years (28218 cases) were the most affected. In both periods incidence in patients older than 65 years was low (rates of 56,3 and 125,1 respectively). In the studied period (weeks 28 at 51) 5481 cases were confirmed, of those that 1746 (31,8%) were hospitalized. The curve of hospitalization rate showed a profile similar to those in primary care and also in microbiological surveillance of the virus. The vaccine effectiveness in the second period was 25% in adults between 15 and 64 years and 51% in those older than 64 years.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>There is an age-dependent protection with positive vaccine efficacy in the elderly, although it may be confounded by natural exposure to the virus, previous immunizations or immune response.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21203724</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>02</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>11</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1135-5727</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>84</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2010 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Revista espanola de salud publica</Title>
<ISOAbbreviation>Rev. Esp. Salud Publica</ISOAbbreviation>
</Journal>
<ArticleTitle>[Pandemic influenza surveillance in the valencian community and seasonal influenza vaccines].</ArticleTitle>
<Pagination>
<MedlinePgn>623-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1135-57272010000500013</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Surveillance of Pandemic influenza was carried out in the Valencian Community. Some effectiveness studies of the seasonal vaccine for AnH1N1 virus have presented no consistent results. The objective of the work consists on describing the results of the epidemic surveillance and effectiveness of the seasonal vaccine for pandemic influenza in the weeks 28 to 51, 2009.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We studied the cases in primary care, hospitalized confirmed, Polimerase Chain Reaction (PCR) and viral isolates and vaccine coverage. Vaccine effectiveness was calculated by the Farrington method of screening method, in three age groups, and two periods: vaccinated 2008-9 and 2009-10 seasons.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In the first period (weeks 28-40) the incidence rates were highest in the group of 15-64 years (7207 cases), followed by those under 15 years (1596 cases). In the second period (weeks 45-47) children under 15 years (28218 cases) were the most affected. In both periods incidence in patients older than 65 years was low (rates of 56,3 and 125,1 respectively). In the studied period (weeks 28 at 51) 5481 cases were confirmed, of those that 1746 (31,8%) were hospitalized. The curve of hospitalization rate showed a profile similar to those in primary care and also in microbiological surveillance of the virus. The vaccine effectiveness in the second period was 25% in adults between 15 and 64 years and 51% in those older than 64 years.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is an age-dependent protection with positive vaccine efficacy in the elderly, although it may be confounded by natural exposure to the virus, previous immunizations or immune response.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Carbó Malonda</LastName>
<ForeName>Rosa María</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>Área de Epidemiología, Dirección General de Salud Pública, Consellería de Sanitat de la Comunitat Valenciana, Valencia, Spain. silvia.fermamdez@salud.madrid.org</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>González Morán</LastName>
<ForeName>Francisco</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vanaclocha Luna</LastName>
<ForeName>Hermelinda</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martín-Sierra Balibrea</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guiral Rodrigo</LastName>
<ForeName>Silvia</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pérez Pérez</LastName>
<ForeName>Elvira</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Castellanos Martínez</LastName>
<ForeName>Teresa</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Grupo de trabajo de Vigilancia Epidemiológica de La Comunitat Valenciana</CollectiveName>
</Author>
</AuthorList>
<Language>spa</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Vigilancia de la gripe pandémica en la Comunidad Valenciana y vacuna antigripal estacional.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Spain</Country>
<MedlineTA>Rev Esp Salud Publica</MedlineTA>
<NlmUniqueID>9600212</NlmUniqueID>
<ISSNLinking>1135-5727</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>2</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21203724</ArticleId>
<ArticleId IdType="pii">S1135-57272010000500013</ArticleId>
<ArticleId IdType="doi">10.1590/s1135-57272010000500013</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Espagne</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Castellanos Martinez, Teresa" sort="Castellanos Martinez, Teresa" uniqKey="Castellanos Martinez T" first="Teresa" last="Castellanos Martínez">Teresa Castellanos Martínez</name>
<name sortKey="Gonzalez Moran, Francisco" sort="Gonzalez Moran, Francisco" uniqKey="Gonzalez Moran F" first="Francisco" last="González Morán">Francisco González Morán</name>
<name sortKey="Guiral Rodrigo, Silvia" sort="Guiral Rodrigo, Silvia" uniqKey="Guiral Rodrigo S" first="Silvia" last="Guiral Rodrigo">Silvia Guiral Rodrigo</name>
<name sortKey="Martin Sierra Balibrea, Miguel" sort="Martin Sierra Balibrea, Miguel" uniqKey="Martin Sierra Balibrea M" first="Miguel" last="Martín-Sierra Balibrea">Miguel Martín-Sierra Balibrea</name>
<name sortKey="Perez Perez, Elvira" sort="Perez Perez, Elvira" uniqKey="Perez Perez E" first="Elvira" last="Pérez Pérez">Elvira Pérez Pérez</name>
<name sortKey="Vanaclocha Luna, Hermelinda" sort="Vanaclocha Luna, Hermelinda" uniqKey="Vanaclocha Luna H" first="Hermelinda" last="Vanaclocha Luna">Hermelinda Vanaclocha Luna</name>
</noCountry>
<country name="Espagne">
<noRegion>
<name sortKey="Carb Malonda, Rosa Maria" sort="Carb Malonda, Rosa Maria" uniqKey="Carb Malonda R" first="Rosa María" last="Carb Malonda">Rosa María Carb Malonda</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000424 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000424 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21203724
   |texte=   [Pandemic influenza surveillance in the valencian community and seasonal influenza vaccines].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21203724" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021